Femoral venous catheterization. Does it really need to be avoided?

Medicina intensiva
Leonardo Lorente, C León

Abstract

The guidelines to prevent central venous catheter related bloodstream infections (CVCBSI) of the Centers for Disease Control and Prevention (CDC) of 2002, Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias/ Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEMICYUC/SEIMC) of 2004, and the recently published guidelines of the Society for Healthcare Epidemiology of America/Infectious Diseases Society of America (SHEA(IDSA) of 2008 have recommended using the subclavian vein and avoiding the use of the femoral vein. They also recommend considering the use of antiseptic- or antimicrobial-impregnated CVCs for hospital units or groups of patients with a high incidence of CVCBSI. When implementing these guidelines, two questions could be asked: 1) Could the abuse of the subclavian vein and avoiding the use of the femoral vein imply a decrease in the incidence of CVCBSI, but an increase in the rate of mechanical complications as pneumothorax and/or hemothorax? 2) Couldn't antimicrobial-impregnated CVCs be used to prevent CVCBSI when the femoral venous access is used?

References

Jan 1, 1991·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·S P GibsonA Odurny
Apr 1, 1991·Critical Care Medicine·J F WilliamsJ E Zimmerman
Jan 1, 1988·Intensive Care Medicine·P CollignonP Woods
May 1, 1987·Archives of Internal Medicine·C Brun-BuissonM Rapin
Jan 1, 1982·Catheterization and Cardiovascular Diagnosis·G W Bo-LinnM D McGoon
Dec 29, 1994·The New England Journal of Medicine·P F MansfieldD M Ota
Jan 1, 1994·JPEN. Journal of Parenteral and Enteral Nutrition·L KempL Flancbaum
May 25, 1994·JAMA : the Journal of the American Medical Association·D PittetR P Wenzel
Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P M ArnowM Beach
Feb 1, 1996·Radiology·G B LundF A Osterman
Aug 10, 2001·JAMA : the Journal of the American Medical Association·J MerrerUNKNOWN French Catheter Study Group in Intensive Care
Dec 4, 2002·American Journal of Infection Control·Naomi P O'gradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Apr 20, 2006·The Journal of Hospital Infection·K B LauplandB J Manns
May 16, 2006·Journal of Intensive Care Medicine·Lewis A EisenRoslyn F Schneider
Jun 30, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David K WarrenUNKNOWN Prevention Epicenter Program
Dec 29, 2006·The New England Journal of Medicine·Peter PronovostChristine Goeschel
Jan 20, 2007·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Goro NagashimaKazuhisa Ugajin
Jan 27, 2007·The Journal of Antimicrobial Chemotherapy·Matthew E FalagasIoannis Chatzinikolaou
Apr 26, 2007·Intensive Care Medicine·Leonardo LorenteMaría L Mora
Jan 25, 2008·Critical Care Medicine·Leonardo LorenteAlejandro Jiménez
Mar 5, 2008·Intensive Care Medicine·John R GowardmanClaire M Rickard
Apr 4, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L LorenteM L Mora
Jul 16, 2008·Intensive Care Medicine·Jose Garnacho-MonteroCarlos Ortiz-Leyba
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonardo LorenteAntonio Sierra
Nov 22, 2008·The Lancet Infectious Diseases·Anna L CaseyTom S J Elliott

❮ Previous
Next ❯

Citations

Dec 17, 2014·Critical Care : the Official Journal of the Critical Care Forum·Leonardo LorenteUNKNOWN Working Group on Catheter Related Infection Suspicion Management of GTEIS/SEMICYUC
Nov 3, 2010·Medicina intensiva·L Lorente
Mar 12, 2010·Medicina intensiva·F Alvarez LermaM P Martínez
Mar 13, 2010·Medicina intensiva·L Lorente, C León
May 7, 2016·World Journal of Critical Care Medicine·Leonardo Lorente
Jun 15, 2021·Irish Journal of Medical Science·Leonardo LorenteAna Madueño

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Leonardo LorenteAntonio Sierra
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Leonardo LorenteMaría L Mora
© 2022 Meta ULC. All rights reserved